Medical Equipment

New Innovative Molecular Technology Combination "LAMP + CRISPR" as CE-IVD

A Collaboration Leads to Molecularbiological Innovation MUNICH, Oct. 20, 2026 /PRNewswire/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new approach, "eazySNP" combines the highly specialized molecular technologies LAM...

2026-10-20 14:10 391

New Innovative Molecular Technology Combination "LAMP + CRISPR" as CE-IVD

A Collaboration Leads to Molecularbiological Innovation MUNICH, Oct. 20, 2026 /PRNewswire/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new approach, "eazySNP" combines the highly specialized molecular technologies LAM...

2026-10-20 14:10 328

Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication

Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 19, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today a...

2026-10-20 09:00 1289

Versiti becomes 10th U.S. blood center to adopt FDA-cleared automation from Terumo Blood and Cell Technologies

Automated whole blood processing will expand platelet production capacity and help meet growing hospital demand LAKEWOOD, Colo. and MILWAUKEE, Oct. 19, 2026 /PRNewswire/ -- Versiti has become the 10th U.S. blood center to adopt the Reveos™ Automated Blood Processing System

2026-10-19 22:00 3872

Alloop Joins CaringKind's 38th Annual Alzheimer's Walk and Brain Health Day

NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Alloop participated in CaringKind's 38th Annual Alzheimer's Walk and Brain Health Day in Central Park on October 17. The team joined the walk and hosted an on-site booth alongside people living with Alzheimer's disease and related demen...

2026-10-19 21:00 1025

Health Innovation South West and Helfie AI announce partnership to evaluate digital-first hypertension screening

Findings from real-world settings will add to the evidence base for preventing cardiovascular disease MELBOURNE, Australia, Oct. 19, 2026 /PRNewswire/ -- Helfie AI and UK-based Health Innovation South West have announced a partnership to explore how digital-first approaches to hypertension scree...

2026-10-19 17:00 2848

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

* Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT). * Secures long-term, priority isotope access for Telix's alpha therapy pipeline, including ...

2026-10-19 13:30 1659

HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES

SINGAPORE, Oct. 19, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the precl...

2026-10-19 11:00 2942

Advanced Manufacturing in Focus: Smart Life and Robotics Take the Spotlight at 140th Canton Fair

GUANGZHOU, China, Oct. 18, 2026 /PRNewswire/ -- Phase 1 of the 140th Canton Fair, themed "Advanced Manufacturing," opened on October 15 and will run through October 19. As one of the event's most closely watched sections, the Consumer Electronics and Information Products zone once again serves as...

2026-10-18 19:00 2594

Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies

ABU DHABI, UAE, Oct. 18, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has concluded its inaugural health and life sciences mission to China, advancing priority areas of collaboration designed to accelerate the translation ...

2026-10-18 01:54 5430

Four Leading Institutions Complete Initial Clinical Experience with Spectrum Dynamics Medical's All-Energy Digital SPECT/CT

Experience at institutions from across the globe demonstrated theranostics and imaging across the validated 40-400 keV range and up to 500 keV, with additional scientific and clinical feasibility experience obtained at higher energies, including applications involving Tc-99m, I-123, Lu-177, I-131...

2026-10-15 20:00 1983

HMI Medical Unveils New Brand Identities Across Its Healthcare Facilities in Malaysia As Regional Cross-border Healthcare Grows

The refreshed identities of HMI Medical's hospitals and medical centre in Malaysia signal the Group's commitment to deliver more with care by sparking change for the future of healthcare SINGAPORE and KUALA LUMPUR, Malaysia, Oct. 15, 2026 /PRNewswire/ -- HMI Medical is strengthening its regional...

2026-10-15 12:25 2999

NTL HEALTHCARE Launches On-Premises AI Solution 'CerviCARE® AI AT' Globally

Supports Local AI Analysis and Data Management, Retains Core CerviCARE® AI Features, and Adds DICOM File Generation SEONGNAM, South Korea, Oct. 15, 2026 /PRNewswire/ -- NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its AI-...

2026-10-15 10:00 1995

Lunit SCOPE Reveals HER2 Expression Differences Linked to Treatment Response Beyond Conventional Testing in Nature Medicine Study

AI-powered whole-slide analysis provides insights into treatment response beyond conventional HER2 classification SEOUL, South Korea, Oct. 14, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced findings from a study p...

2026-10-14 21:00 2133

Neurophet Honored with Two Awards at the BioSpectrum Asia Excellence Awards 2026

* Receives Awards for MedTech Innovation and AI-Driven Clinical Development; Only Korean Company Recognized in Two Categories * Recognized for its capabilities in AI-driven clinical support and ICL services, with plans to expand partnerships with global CROs SEOUL, South Korea, Oct. 14, 2026 /...

2026-10-14 21:00 1876

MIRACELL to Host Stem Cell Science Day 2026 in Los Angeles, Featuring International Clinical Insights in Regenerative Medicine

- Leading South Korean and U.S. medical experts to share clinical insights into regenerative medicine - Austrian clinical study on 47 ACL rupture patients treated with SMART M-CELL published in peer-reviewed journal LOS ANGELES, Oct. 14, 2026 /PRNewswire/ -- Miracell U.S. Inc., the U.S. subsidi...

2026-10-14 19:00 1552

Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM

MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that 20 company-related abstracts will be presented at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in ...

2026-10-14 13:00 2613

ELEHEAR Earns Two 2026 Hearing Technology Innovator Awards™ from Hearing Health & Technology Matters

Beyond 2 Pro and ElePro® Plus awarded industry recognition as ELEHEAR continues its mission to make personalized hearing care more accessible CHICAGO, Oct. 13, 2026 /PRNewswire/ -- ELEHEAR , a company specializing in AI-powered hearing solutions, has been named a two-time w...

2026-10-13 19:00 1949

The Right Doctor Isn't Always One Doctor

Why complex brain and spine conditions increasingly call for specialists to work across disciplines.   KUALA LUMPUR, Malaysia, Oct. 13, 2026 /PRNewswire/ -- When faced with a brain, spine or neurological condition, one of the first questions a patient or family member may ask is: Which doctor sh...

2026-10-13 16:15 1565

SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease

LUCERNE, Switzerland and NEW DELHI, Oct. 13, 2026 /PRNewswire/ -- The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the launch of the multinational randomized trial evaluating a drug-coated balloon (DCB)-first strategy against contemporary drug-eluting sten...

2026-10-13 02:11 3118
12345 ... 147